X4 Pharmaceuticals CFO David Kirske Sells $36,428 in Common Stock
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Chief Financial Officer David Kirske executed a transaction involving the sale of 8,543 shares of the company's common stock on June 30, 2026. The divestment, valued at $36,428, was facilitated to satisfy personal income tax liabilities stemming from the settlement of a restricted stock unit award. Kirske's sa…